weight plateau on semaglutide Overcoming Loss Plateaus with – Synchronicity Health Semaglutide - Effective Medical Weight

After a year of taking semaglutide, marketed as Wegovy by Novo Nordisk, patients risk of suffering from conditions like a heart attack or a stroke over the next 10 years dropped to 6.3% from 7.6% when measured by a commonly used calculator, researchers at the Mayo Clinic found

Elective Surgery High-risk elective cases joint arthroplasty, major abdominal surgery require tighter protocols

Ram Sohan P, Mahakalkar C, Kshirsagar S, Bikkumalla S, Reddy S, Hatewar A, et al

Wegovy, like all medications, can cause side effects, although not everyone will get them

median age 50 years, 72% women) were no longer taking it after one year -- with 18%, 31% and 42% stopping treatment within 3, 6 and 9 months, respectively